Antiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulation

Human Reproduction

Volumn 23, Issue 9, 2008, Pages 2095-2103

  Le Tortorec, A ^a,b   Denis, H ^a,b   Satie, A P ^a,b   Patard, J J ^c   Ruffault, A ^c   Jegou B ^a,b   Dejucq Rainsford, N ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Antiviral proteins; Humans; Interferons; Leydig cells; Mumps virus

Indexed keywords

2' 5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; MESSENGER RNA; MYXOVIRUS RESISTANCE PROTEIN A; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN; PROTEIN KINASE R; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INHIBITION KINETICS; INNATE IMMUNITY; LEYDIG CELL; MALE; MALE STERILITY; MUMPS; MUMPS VIRUS; PROTEIN EXPRESSION; RNA VIRUS; VIRUS REPLICATION;

MUMPS VIRUS; RATTUS; RNA VIRUSES;

EID: 54149086774     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den207     Document Type: Article

References (61)

1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-738.
2. Anthony CT, Skinner MK. Cytochemical and biochemical characterization of testicular peritubular myoid cells. Biol Reprod 1989;40:811-823.
3. Barlow DP, Randle BJ, Burke DC. Interferon synthesis in the early post-implantation mouse embryo. Differentiation 1984;27:229-235.
4. Bigazzi PL, Barron AL, Flanagan TD, Andrada JA, Witebsky E. Growth of mumps virus in organ cultures of rhesus testis. J Infect Dis 1968;118:411-421.
5. Bjorvatn B. Mumps virus recovered from testicles by fine-needle aspiration biopsy in cases of mumps orchitis. Scand J Infect Dis 1973;5:3-5.
6. Casado M, Vallet VS, Kahn A, Vaulont S. Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver. J Biol Chem 1999;274:2009-2013.
7. Cudicini C, Lejeune H, Gomez E, Bosmans E, Ballet F, Saez J, Jégou B. Human leydig cells and sertoli cells are producers of interleukins-1 and 6. J Clin Endocrinol Metab 1997;82:1426-1433.
8. De Maeyer E, Skup D, Prasad KS, De Maeyer-Guignard J, Williams B, Meacock P, Sharpe G, Pioli D, Hennam J, Schuch W et al. Expression of a chemically synthesized human alpha 1 interferon gene. Proc Natl Acad Sci USA 1982;79:4256-4259.
9. Dejucq N, Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev 2001;65: 208-231.
10. Dejucq N, Dugast I, Ruffault A, Van Der Meide PH, Jégou B. Interferon-alpha and -gamma expression in the rat testis. Endocrinology 1995;136: 4925-4931.
11. Dejucq N, Chousterman S, Jegou B. The testicular antiviral defense system: localization, expression, and regulation of 2050 oligoadenylate synthetase, double-stranded RNA-activated protein kinase, and Mx proteins in the rat seminiferous tubule. J Cell Biol 1997;139:865-873.
12. Dejucq N, Liénard Mo, Guillaume E, Dorval I, Jégou B. Expression of interferons-alpha and gamma in testicular interstitial tissue and spermatogonia of the rat. Endocrinology 1998;139:3081-3087.
13. Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C, Grez M, Thrasher AJ. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 2002;13:803-813.
14. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 1998;95:15623- 15628.
15. Erpenbach KHJ. Systemic treatment with interferon-alpha 2 B: an effective method to prevent sterility after bilateral mumps orchitis. J Urol 1991;146:54-56.
16. Francois C, Duverlie G, Rebouillat D, Khorsi H, Castelain S, Blum He, Gatignol A, Wychowski C, Moradpour D, Meurs EF. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J Virol 2000;74:5587- 5596.
17. Fujii N, Yokosawa N, Shirakawa S. Suppression of interferon response gene expression in cells persistently infected with mumps virus, and restoration from its suppression by treatment with ribavirin. Virus Res 1999;65: 175-185.
18. Gessani S, Puddu P, Varano B, Borghi P, Conti L, Fantuzzi L, Belardelli F. Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication. J Virol 1994;68:1983-1986.
19. Goodbourn S, Didcock L, Randall RE. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 2000;81:2341-2364.
20. Grandvaux N, Servant MJ, Tenoever B, Sen GC, Balachandran S, Barber GN, Lin R, Hiscott J. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 2002;76:5532-5539.
21. Gray A, Guillou L, Zufferey J, Rey F, Kurt AM, Jichlinski P, Leisinger HJ, Benhattar J. Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours. J Gen Virol 1998;79:573-579.
22. Guillaume E, Evrard B, Com E, Moertz E, Jegou B, Pineau C. Proteome analysis of rat spermatogonia: reinvestigation of stathmin spatio-temporal expression within the testis. Mol Reprod Dev 2001;60:439-445.
23. Hedger MP, Meinhardt A. Cytokines and the immune-testicular axis. J Reprod Immunol 2003;58:1-26.
24. Hengel H, Koszinowski UH, Conzelmann KK. Viruses know it all: new insights into IFN networks. Trends Immunol 2005;26:396-401.
25. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 2007;282:15325-15329.
26. Katze MG, He Y, Gale M, Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002;2:675-687.
27. Ku JH, Kim YH, Jeon YS, Lee NK. The preventive effect of systemic treatment with interferon-alpha2B for infertility from mumps orchitis. BJU Int 1999;84:839-842.
28. Kubota T, Yokosawa N, Yokota S, Fujii N. C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha. Biochem Biophys Res Commun 2001;283:255-259.
29. Kubota T, Yokosawa N, Yokota S, Fujii N. Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex. J Virol 2002;76:12676-12682.
30. Kubota T, Yokosawa N, Yokota S, Fujii N, Tashiro M, Kato A. Mumps virus V protein antagonizes interferon without the complete degradation of STAT1. J Virol 2005;79:4451-4459.
31. Le Goffic R, Mouchel T, Ruffault A, Patard JJ, Jegou B, Samson M. Mumps virus decreases testosterone production and gamma interferon-induced protein 10 secretion by human leydig cells. J Virol 2003;77:3297-3300.
32. Le Page C, Genin P, Baines MG, Hiscott J. Interferon activation and innate immunity. Rev Immunogenet 2000;2:374-386.
33. Lin R, Genin P, Mamane Y, Hiscott J. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol 2000;20:6342-6353.
34. Lopez S, Navarro S. Transcriptional repression of type I IFN genes. Biochimie 1998;80:689-701.
35. Lutfalla G, Gardiner K, Proudhon D, Vielh E, Uze G. The structure of the human interferon alpha/beta receptor gene. J Biol Chem 1992;267: 2802-2809.
36. Maddocks S, Setchell BP. Recent evidence for immune privilege in the testis. J Reprod Immunol 1990;18:9-18.
37. Malmgaard L, Melchjorsen J, Bowie AG, Mogensen SC, Paludan SR. Viral activation of macrophages through TLR-dependent and -independent pathways. J Immunol 2004;173:6890-6898.
38. Meduri G, Charnaux N, Loosfelt H, Jolivet A, Spyratos F, Brailly S, Milgrom E. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res 1997;57:857-864.
39. Melaine N, Liénard MO, Guillaume E, Ruffault A, Dejucq-Rainsford N, Jégou B. Production of the antiviral proteins 2′5′ Oligoadenylate synthetase, PKR and Mx proteins in interstitial cells and spermatogonia. Hum Reprod Immunol 2003;59:53-60.
40. Nagata S, Mantei N, Weissmann C. The structure of one of the eight or more distinct chromosomal genes for human interferon-a. Nature 1980;287:401-407.
41. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272:263-267.
42. Nicholl MJ, Robinson LH, Preston CM. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J Gen Virol 2000;81:2215-2218.
43. Nourbakhsh M, Hauser H. Constitutive silencing of IFN-beta promoter is mediated by NRF (NF-kappaB-repressing factor), a nuclear inhibitor of NF-kappaB. EMBO J 1999;18:6415-6425.
44. Pfitzer P, Gilbert P, Rolz G, Vyska K. Flow cytometry of human testicular tissue. Cytometry 1982;3:116-122.
45. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984;12:1687-1696.
46. Preston CM, Harman AN, Nicholl MJ. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 2001;75:8909-8916.
47. Ren B, Chee KJ, Kim TH, Maniatis T. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev 1999;13:125-137.
48. Ronni T, Melen K, Malygin A, Julkunen I. Control of IFN-inducible MxA gene expression in human cells. J Immunol 1993;150:1715-1726.
49. Roulet V, Denis H, Staub C, Le Tortorec A, Delaleu B, Satie AP, Patard JJ, Jégou B, Dejucq-Rainsford N. Human testis in organotypic culture: application for basic or clinical research. Hum Reprod 2006;21:1564-1575.
50. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-386.
51. Rubinstein S, Familletti PC, Pestka S. Convenient assay for interferons. J Virol 1981;37:755-758.
52. Ruffault A, Genetet N, Berthier AM, Pommereuil M, Duvail C, Andre P, Morel H, Genetet B, Fauconnier B. Interferon production in severe hemophiliacs with and without HIV antibodies. J Interferon Res 1992;Spec No:45-50.
53. Ruffault A, Michelet C, Jacquelinet C, Guist'hau O, Genetet N, Bariou C, Colimon R, Cartier F. The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:243-248.
54. Ruther U, Stilz S, Rohl E, Nunnensiek C, Rassweiler J, Dorr U, Jipp P. Successful interferon alpha 2 a therapy for a patient with acute mumps orchitis. Eur Urol 1995;27:174-176.
55. Samarajiwa SA, Wilson W, Hertzog PJ. Type I interferons: genetics and structure. In: Meager A (ed). The Interferons: Characterization and Application. Weinheim: Wiley-VCH Verlag GmbH & Co., 2006,3-34.
56. Sen GC. Viruses and interferons. Annu Rev Microbiol 2001;55:255-281.
57. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998;67:227-264.
58. Taya Y, Devos R, Tavernier J, Cheroutre H, Engler G, Fiers W. Cloning and structure of the human immune interferon-gamma chromosomal gene. EMBO J 1982;1:953-958.
59. Uematsu S, Akira S. Toll-like receptors and type I interferons. J Biol Chem 2007;282:15319-15323.
60. Uze G, Monneron D. IL-28 and IL-29: newcomers to the interferon family. Biochimie 2007;89:729-734.
61. Willey S, Roulet V, Reeves JD, Kergadallan M-L, Thomas E, Mcknight A, Jégou B, Dejucq-Rainsford N. Human Leydig cells are productively infected by some HIV-2 and SIV strains but not by HIV-1. AIDS 2003;17:183-188.